Millipore Sigma Vibrant Logo

504528 NVP-AAM077 Tetrasodium Hydrate - CAS 459836-30-7 - Calbiochem

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: NMDA Antagonist VII, NVP-AAM077, [[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium hydrate, PEAQX tetrasodium hydrate

Primary Target: NMDA receptors
View Products on Sigmaaldrich.com
504528
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
459836-30-7C₁₇H₁₇BrN₃Na₄O₆P

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
5.04528.0001
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Flacon en verre 5 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewA potent antagonist for NMDA receptors. Modestly higher selectivity for the NR2A than for the NR2B containing NMDA receptors (IC50 = 0.015 and 0.078 µM) but insufficient to discriminate between NR2A and NR2B-containing NMDA receptors. Widely used for researches in synaptic plastic, learning and memory, and epilepsy.
      Catalogue Number504528
      Brand Family Calbiochem®
      SynonymsNMDA Antagonist VII, NVP-AAM077, [[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium hydrate, PEAQX tetrasodium hydrate
      References
      ReferencesFrizelle. P., et al. 2006. Mol. Pharmacol. 70, 1022.
      Milton, A., et al. 2013. J. Neurosci. 33, 1109.
      Kochlamazashvili, G., et al. 2012. J. Neurosci. 32, 2263.
      Kocsis, B., et al. 2012. Sleep. 35, 1011.
      Product Information
      CAS number459836-30-7
      FormWhite solid
      Hill FormulaC₁₇H₁₇BrN₃Na₄O₆P
      Chemical formulaC₁₇H₁₇BrN₃Na₄O₆P
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetNMDA receptors
      Primary Target IC<sub>50</sub>0.015 and 0.078 µM for NR2A and NR2B, respectively.
      Purity≥99% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      5.04528.0001 04055977263756

      Documentation

      NVP-AAM077 Tetrasodium Hydrate - CAS 459836-30-7 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      NVP-AAM077 Tetrasodium Hydrate - CAS 459836-30-7 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      504528

      Références bibliographiques

      Aperçu de la référence bibliographique
      Frizelle. P., et al. 2006. Mol. Pharmacol. 70, 1022.
      Milton, A., et al. 2013. J. Neurosci. 33, 1109.
      Kochlamazashvili, G., et al. 2012. J. Neurosci. 32, 2263.
      Kocsis, B., et al. 2012. Sleep. 35, 1011.

      Brochure

      Titre
      Pathways and Biomarkers of Glutamatergic Synapse Flyer
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision06-March-2015 JSW
      SynonymsNMDA Antagonist VII, NVP-AAM077, [[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium hydrate, PEAQX tetrasodium hydrate
      DescriptionA potent antagonist for NMDA receptors. Modestly higher selectivity for the NR2A than for the NR2B containing NMDA receptors (IC50 = 0.015 and 0.078 µM) but insufficient to discriminate between NR2A and NR2B-containing NMDA receptors. Widely used for researches in synaptic plastic, learning and memory, and epilepsy.
      FormWhite solid
      CAS number459836-30-7
      Chemical formulaC₁₇H₁₇BrN₃Na₄O₆P
      Structure formulaStructure formula
      Purity≥99% by HPLC
      SolubilityH₂O (24 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesFrizelle. P., et al. 2006. Mol. Pharmacol. 70, 1022.
      Milton, A., et al. 2013. J. Neurosci. 33, 1109.
      Kochlamazashvili, G., et al. 2012. J. Neurosci. 32, 2263.
      Kocsis, B., et al. 2012. Sleep. 35, 1011.